Marta Peciña

University of Pittsburgh — United States

Neuroscience · Life Sciences

23h-index2.2kcitations51works2.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Management and Placebo Effect(28), Treatment of Major Depression(13), Neuroscience, Education and Cognitive Function(13), Functional Brain Connectivity Studies(10), Pain Mechanisms and Treatments(7)

Publications51 total

Relationships between Mu-opioid receptors brain expression and depressive-like behaviors in animal models: A systematic review
Neuroscience & Biobehavioral Reviews·2025
Expectancy-Mood Neural Dynamics Predict Mechanisms of Short- and Long-Term Antidepressant Placebo Effects
Biological Psychiatry Cognitive Neuroscience and Neuroimaging·2025Open Access
Expectancy-mood neural dynamics predict antidepressant placebo effects
Brain stimulation·2025Open Access
The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies
Biological Psychiatry·2024· 1 citedOpen Access
Efficacy of medications for the treatment of alcohol use disorder (AUD): A systematic review and meta-analysis considering baseline AUD severity
Pharmacological Research·2024· 13 citedOpen Access
151. Salience and Default Mode Network Coupling Role in Expectancy-Mood Interactions in Depression
Biological Psychiatry·2024· 1 cited
New translational opportunities for placebo research
2023Open Access
Molecular mechanisms of placebo responses
2023· 2 citedOpen Access
8. dmPFC Causal Modulation of Antidepressant Expectancies
Biological Psychiatry·2023
Dynamic Feedback Between Antidepressant Placebo Expectancies and Mood
JAMA Psychiatry·2023· 9 citedOpen Access
MRI predictors of pharmacotherapy response in major depressive disorder
NeuroImage Clinical·2022· 55 citedOpen Access
What can be done to control the placebo response in clinical trials? A narrative review
Contemporary Clinical Trials·2021· 36 citedOpen Access
μ Opioid Antagonist Naltrexone Partially Abolishes the Antidepressant Placebo Effect and Reduces Orbitofrontal Cortex Encoding of Reinforcement
Biological Psychiatry Cognitive Neuroscience and Neuroimaging·2021· 6 citedOpen Access
Understanding the Neurocomputational Mechanisms of Antidepressant Placebo Effects
Journal of Psychiatry and Brain Science·2021· 2 citedOpen Access
Personality Trait Predictors of Placebo Analgesia and Neurobiological Correlates
UNC Libraries·2020Open Access
Naltrexone modulates contextual processing in depression
Neuropsychopharmacology·2020· 6 citedOpen Access
Neural Correlates of Antidepressant Expectancies Positively Moderate Antidepressant Treatment Response to Placebo but Not Escitalopram in Major Depression
Biological Psychiatry·2020
Opioid Exposure Negatively Affects Antidepressant Response to Venlafaxine in Older Adults with Chronic Low Back Pain and Depression
Pain Medicine·2019· 13 citedOpen Access
Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities
Frontiers in Psychiatry·2019· 11 citedOpen Access
Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression
NeuroImage Clinical·2019· 17 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jon-Kar Zubieta(12), Christian S. Stohler(11), Tiffany Love(10), Brian J. Mickey(10), Scott A. Langenecker(9), Alexandre Y. Dombrovski(9), Helmet T. Karim(8), David Goldman(7), Jon‐Kar Zubieta(7), Joseph Heffernan(7), Jordan F. Karp(6), Erich T. Avery(6), Colin A. Hodgkinson(6), Sara L. Weisenbach(6), David T. Hsu(4), Robert C. Welsh(4), J. Zubieta(4), Kevin Handoko(4), Alyssa Neppach(4), Magdalena Sikora(3)